{"count": 19, "results": [{"_id": "32051330", "pmid": 32051330, "title": "Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis.", "journal": "Hong Kong Med J", "authors": ["Leung KL", "Fong W", "Freedman B", "Bajorek B", "Lee VWY"], "date": "2020-02-01T00:00:00Z", "doi": "10.12809/hkmj198077", "meta_date_publication": "2020 Feb", "meta_volume": "26", "meta_issue": "1", "meta_pages": "27-34", "score": 50249.547, "text_hl": "After adjusting for other weight-altering drugs, beta-blockers remained a significant predictor of @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@ and @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obesity@@@ (P=0.001). As the @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ population had significantly higher BMI than the normotensive population (24.3+-3.6 vs 22.9+-3.5, P<0.001), a sub-analysis on those with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ diagnosis confirmed that only the @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ population taking @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ had a significantly larger population of @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese@@@ individuals (BMI >=25) compared with those who took @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ (58.9% vs 38.5%, P=0.03) and those who did not take any beta-blockers (58.9% vs 38.4%, P=0.007). ", "citations": {"NLM": "Leung KL, Fong W, Freedman B, Bajorek B, Lee VWY. Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis. Hong Kong Med J. 2020 Feb;26(1):27-34. PMID: 32051330", "BibTeX": "@article{32051330, title={Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis.}, author={Leung KL and Fong W and Freedman B and Bajorek B and Lee VWY}, journal={Hong Kong Med J}, volume={26}, number={1}, pages={27-34}}"}}, {"_id": "3757816", "pmid": 3757816, "title": "[Atenolol poisoning].", "journal": "Dtsch Med Wochenschr", "authors": ["Hagemann K"], "date": "1986-10-03T00:00:00Z", "doi": "10.1055/s-2008-1068665", "meta_date_publication": "1986 Oct 3", "meta_volume": "111", "meta_issue": "40", "meta_pages": "1523-5", "score": 50069.664, "text_hl": "...A 44-year-old @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese@@@ female @SPECIES_9606 @@@patient@@@ ingested 200 mg @CHEMICAL_Diazepam @CHEMICAL_MESH:D003975 @@@diazepam@@@ and 1000 mg @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ with suicidal intent. ", "citations": {"NLM": "Hagemann K. [Atenolol poisoning]. Dtsch Med Wochenschr. 1986 Oct 3;111(40):1523-5. PMID: 3757816", "BibTeX": "@article{3757816, title={[Atenolol poisoning].}, author={Hagemann K}, journal={Dtsch Med Wochenschr}, volume={111}, number={40}, pages={1523-5}}"}}, {"_id": "12784321", "pmid": 12784321, "title": "Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.", "journal": "Biopharm Drug Dispos", "authors": ["Wójcicki J", "Jaroszynska M", "Droździk M", "Pawlik A", "Gawrońska-Szklarz B", "Sterna R"], "date": "2003-07-01T00:00:00Z", "doi": "10.1002/bdd.357", "meta_date_publication": "2003 Jul", "meta_volume": "24", "meta_issue": "5", "meta_pages": "211-8", "score": 50064.51, "text_hl": "The concentrations of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ were significantly lower in both normolipaemic and hyperlipidaemic @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese@@@ subjects. ", "citations": {"NLM": "Wójcicki J, Jaroszynska M, Droździk M, Pawlik A, Gawrońska-Szklarz B, Sterna R. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. Biopharm Drug Dispos. 2003 Jul;24(5):211-8. PMID: 12784321", "BibTeX": "@article{12784321, title={Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.}, author={Wójcicki J and Jaroszynska M and Droździk M and Pawlik A and Gawrońska-Szklarz B and Sterna R}, journal={Biopharm Drug Dispos}, volume={24}, number={5}, pages={211-8}}"}}, {"_id": "16269974", "pmid": 16269974, "title": "Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.", "journal": "J Hypertens", "authors": ["Jordan J", "Engeli S", "Boschmann M", "Weidinger G", "Luft FC", "Sharma AM", "Kreuzberg U"], "date": "2005-12-01T00:00:00Z", "doi": "10.1097/01.hjh.0000188734.98463.82", "meta_date_publication": "2005 Dec", "meta_volume": "23", "meta_issue": "12", "meta_pages": "2313-8", "score": 50064.06, "text_hl": "Hemodynamic and metabolic responses to @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese hypertensive@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Jordan J, Engeli S, Boschmann M, Weidinger G, Luft FC, Sharma AM, Kreuzberg U. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients. J Hypertens. 2005 Dec;23(12):2313-8. PMID: 16269974", "BibTeX": "@article{16269974, title={Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.}, author={Jordan J and Engeli S and Boschmann M and Weidinger G and Luft FC and Sharma AM and Kreuzberg U}, journal={J Hypertens}, volume={23}, number={12}, pages={2313-8}}"}}, {"_id": "9819786", "pmid": 9819786, "title": "Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.", "journal": "Maturitas", "authors": ["Stimpel M", "Koch B", "Weber MA"], "date": "1998-09-20T00:00:00Z", "doi": "10.1016/s0378-5122(98)00037-1", "meta_date_publication": "1998 Sep 20", "meta_volume": "30", "meta_issue": "1", "meta_pages": "69-77", "score": 50062.637, "text_hl": "Comparison between @CHEMICAL_moexipril @CHEMICAL_MESH:C058302 @@@moexipril@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese@@@ postmenopausal @SPECIES_9606 @@@women@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@.", "citations": {"NLM": "Stimpel M, Koch B, Weber MA. Comparison between moexipril and atenolol in obese postmenopausal women with hypertension. Maturitas. 1998 Sep 20;30(1):69-77. PMID: 9819786", "BibTeX": "@article{9819786, title={Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.}, author={Stimpel M and Koch B and Weber MA}, journal={Maturitas}, volume={30}, number={1}, pages={69-77}}"}}, {"_id": "9241674", "pmid": 9241674, "title": "Antenatal exposure to atenolol and retroperitoneal fibromatosis.", "journal": "Reprod Toxicol", "authors": ["Satgé D", "Sasco AJ", "Col JY", "Lemonnier PG", "Hemet J", "Robert E"], "date": "1997-07-01T00:00:00Z", "doi": "10.1016/s0890-6238(97)00021-x", "meta_date_publication": "1997 Jul-Aug", "meta_volume": "11", "meta_issue": "4", "meta_pages": "539-41", "score": 50061.082, "text_hl": "A 25-year-old @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese@@@ @SPECIES_9606 @@@woman@@@ was treated for @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ with 100 mg @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ daily from the second month until the end of pregnancy. ", "citations": {"NLM": "Satgé D, Sasco AJ, Col JY, Lemonnier PG, Hemet J, Robert E. Antenatal exposure to atenolol and retroperitoneal fibromatosis. Reprod Toxicol. 1997 Jul-Aug;11(4):539-41. PMID: 9241674", "BibTeX": "@article{9241674, title={Antenatal exposure to atenolol and retroperitoneal fibromatosis.}, author={Satgé D and Sasco AJ and Col JY and Lemonnier PG and Hemet J and Robert E}, journal={Reprod Toxicol}, volume={11}, number={4}, pages={539-41}}"}}, {"_id": "7475056", "pmid": 7475056, "title": "Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol.", "journal": "J Cardiovasc Pharmacol", "authors": ["Morel Y", "Gadient A", "Keller U", "Vadas L", "Golay A"], "date": "1995-08-01T00:00:00Z", "doi": "10.1097/00005344-199508000-00017", "meta_date_publication": "1995 Aug", "meta_volume": "26", "meta_issue": "2", "meta_pages": "306-11", "score": 50056.08, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@ sensitivity in @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese@@@ @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ dyslipidemic @SPECIES_9606 @@@patients@@@ treated with @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@.", "citations": {"NLM": "Morel Y, Gadient A, Keller U, Vadas L, Golay A. Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol. J Cardiovasc Pharmacol. 1995 Aug;26(2):306-11. PMID: 7475056", "BibTeX": "@article{7475056, title={Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol.}, author={Morel Y and Gadient A and Keller U and Vadas L and Golay A}, journal={J Cardiovasc Pharmacol}, volume={26}, number={2}, pages={306-11}}"}}, {"_id": "3516792", "pmid": 3516792, "title": "Effects of ephedrine and atenolol on the development of obesity and diabetes in ob/ob mice.", "journal": "Gen Pharmacol", "authors": ["Bailey CJ", "Thornburn CC", "Flatt PR"], "date": "1986-01-01T00:00:00Z", "doi": "10.1016/0306-3623(86)90147-3", "meta_date_publication": "1986", "meta_volume": "17", "meta_issue": "2", "meta_pages": "243-6", "score": 50054.64, "text_hl": "Effects of @CHEMICAL_Ephedrine @CHEMICAL_MESH:D004809 @@@ephedrine@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on the development of @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obesity@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ in @GENE_LEP @GENE_16846 @@@ob@@@/@CELLLINE_CVCL:S603 @@@ob@@@ @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Bailey CJ, Thornburn CC, Flatt PR. Effects of ephedrine and atenolol on the development of obesity and diabetes in ob/ob mice. Gen Pharmacol. 1986;17(2):243-6. PMID: 3516792", "BibTeX": "@article{3516792, title={Effects of ephedrine and atenolol on the development of obesity and diabetes in ob/ob mice.}, author={Bailey CJ and Thornburn CC and Flatt PR}, journal={Gen Pharmacol}, volume={17}, number={2}, pages={243-6}}"}}, {"_id": "9140673", "pmid": 9140673, "title": "Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.", "journal": "Cardiovasc Drugs Ther", "authors": ["Bönner G", "Schmieder R", "Chrosch R", "Weidinger G"], "date": "1997-03-01T00:00:00Z", "doi": "10.1023/a:1007735420758", "meta_date_publication": "1997 Mar", "meta_volume": "11", "meta_issue": "1", "meta_pages": "21-6", "score": 50054.15, "text_hl": "Effect of @CHEMICAL_bunazosin @CHEMICAL_MESH:C018176 @@@bunazosin@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ metabolism in @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese@@@, nondiabetic @SPECIES_9606 @@@patients@@@ with primary @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@.", "citations": {"NLM": "Bönner G, Schmieder R, Chrosch R, Weidinger G. Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension. Cardiovasc Drugs Ther. 1997 Mar;11(1):21-6. PMID: 9140673", "BibTeX": "@article{9140673, title={Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.}, author={Bönner G and Schmieder R and Chrosch R and Weidinger G}, journal={Cardiovasc Drugs Ther}, volume={11}, number={1}, pages={21-6}}"}}, {"_id": "11023935", "pmid": 11023935, "title": "Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: A randomized, double-blind, controlled study of 21 obese hypertensives.", "journal": "Circulation", "authors": ["Kuperstein R", "Sasson Z"], "date": "2000-10-10T00:00:00Z", "doi": "10.1161/01.cir.102.15.1802", "meta_date_publication": "2000 Oct 10", "meta_volume": "102", "meta_issue": "15", "meta_pages": "1802-6", "score": 50052.5, "text_hl": "CONCLUSIONS: In @<m>DISEASE_Obesity</m> @DISEASE_MESH:D009765 @@@obese@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ individuals, adequate and similar blood pressure control was achieved with @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Kuperstein R, Sasson Z. Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: A randomized, double-blind, controlled study of 21 obese hypertensives. Circulation. 2000 Oct 10;102(15):1802-6. PMID: 11023935", "BibTeX": "@article{11023935, title={Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: A randomized, double-blind, controlled study of 21 obese hypertensives.}, author={Kuperstein R and Sasson Z}, journal={Circulation}, volume={102}, number={15}, pages={1802-6}}"}}]}